U Fransson1, A H Rosengren, F C Schuit, E Renström, H Mulder. 1. Department of Experimental Medical Science,Division of Diabetes, Metabolism, and Endocrinology, Lund University, Lund, Sweden. ulrika.fransson@med.lu.se
Abstract
AIMS/HYPOTHESIS: The molecular mechanisms of insulin release are only partially known. Among putative factors for coupling glucose metabolism to insulin secretion, anaplerosis has lately received strong support. The anaplerotic enzyme pyruvate carboxylase is highly expressed in beta cells, and anaplerosis influences insulin secretion in beta cells. By inhibiting pyruvate carboxylase in rat islets, we aimed to clarify the hitherto unknown metabolic events underlying anaplerotic regulation of insulin secretion. METHODS: Phenylacetic acid (5 mmol/l) was used to inhibit pyruvate carboxylase in isolated rat islets, which were then assessed for insulin secretion, fuel oxidation, ATP:ADP ratio, respiration, mitochondrial membrane potential, exocytosis and ATP-sensitive K(+) channel (K(ATP)-channel) conductance. RESULTS: We found that the glucose-provoked rise in ATP:ADP ratio was suppressed by inhibition of pyruvate carboxylase. In contrast, fuel oxidation, respiration and mitochondrial membrane potential, as well as Ca(2+)-induced exocytosis and K(ATP)-channel conductance in single cells, were unaffected. Insulin secretion induced by alpha-ketoisocaproic acid was suppressed, whereas methyl-succinate-stimulated secretion remained unchanged. Perifusion of rat islets revealed that inhibition of anaplerosis decreased both the second phase of insulin secretion, during which K(ATP)-independent actions of fuel secretagogues are operational, as well as the first and K(ATP)-dependent phase. CONCLUSIONS/ INTERPRETATION: Our results are consistent with the concept that anaplerosis via pyruvate carboxylase determines pyruvate cycling, which has previously been shown to correlate with glucose responsiveness in clonal beta cells. These processes, controlled by pyruvate carboxylase, seem crucial for generation of an appropriate ATP:ADP ratio, which may regulate both phases of fuel-induced insulin secretion.
AIMS/HYPOTHESIS: The molecular mechanisms of insulin release are only partially known. Among putative factors for coupling glucose metabolism to insulin secretion, anaplerosis has lately received strong support. The anaplerotic enzyme pyruvate carboxylase is highly expressed in beta cells, and anaplerosis influences insulin secretion in beta cells. By inhibiting pyruvate carboxylase in rat islets, we aimed to clarify the hitherto unknown metabolic events underlying anaplerotic regulation of insulin secretion. METHODS:Phenylacetic acid (5 mmol/l) was used to inhibit pyruvate carboxylase in isolated rat islets, which were then assessed for insulin secretion, fuel oxidation, ATP:ADP ratio, respiration, mitochondrial membrane potential, exocytosis and ATP-sensitive K(+) channel (K(ATP)-channel) conductance. RESULTS: We found that the glucose-provoked rise in ATP:ADP ratio was suppressed by inhibition of pyruvate carboxylase. In contrast, fuel oxidation, respiration and mitochondrial membrane potential, as well as Ca(2+)-induced exocytosis and K(ATP)-channel conductance in single cells, were unaffected. Insulin secretion induced by alpha-ketoisocaproic acid was suppressed, whereas methyl-succinate-stimulated secretion remained unchanged. Perifusion of rat islets revealed that inhibition of anaplerosis decreased both the second phase of insulin secretion, during which K(ATP)-independent actions of fuel secretagogues are operational, as well as the first and K(ATP)-dependent phase. CONCLUSIONS/ INTERPRETATION: Our results are consistent with the concept that anaplerosis via pyruvate carboxylase determines pyruvate cycling, which has previously been shown to correlate with glucose responsiveness in clonal beta cells. These processes, controlled by pyruvate carboxylase, seem crucial for generation of an appropriate ATP:ADP ratio, which may regulate both phases of fuel-induced insulin secretion.
Authors: Rosita Ivarsson; Roel Quintens; Sandra Dejonghe; Katsura Tsukamoto; Peter in 't Veld; Erik Renström; Frans C Schuit Journal: Diabetes Date: 2005-07 Impact factor: 9.461
Authors: Claudio C Zoppi; Vivian C Calegari; Leonardo R Silveira; Everardo M Carneiro; Antonio C Boschero Journal: Eur J Appl Physiol Date: 2011-02-02 Impact factor: 3.078
Authors: Mette V Jensen; Jonathan M Haldeman; Hengtao Zhang; Danhong Lu; Mark O Huising; Wylie W Vale; Hans E Hohmeier; Paul Rosenberg; Christopher B Newgard Journal: J Biol Chem Date: 2013-06-20 Impact factor: 5.157
Authors: Siri Malmgren; David G Nicholls; Jalal Taneera; Karl Bacos; Thomas Koeck; Ashkan Tamaddon; Rolf Wibom; Leif Groop; Charlotte Ling; Hindrik Mulder; Vladimir V Sharoyko Journal: J Biol Chem Date: 2009-09-21 Impact factor: 5.157
Authors: Seung-Ryoung Jung; Iok Teng Denise Kuok; Drew Couron; Norma Rizzo; Daciana H Margineantu; David M Hockenbery; Francis Kim; Ian R Sweet Journal: J Biol Chem Date: 2011-03-10 Impact factor: 5.157
Authors: Geert A Martens; Lei Jiang; Katrijn Verhaeghen; Joanne B Connolly; Scott G Geromanos; Geert Stangé; Laurence Van Oudenhove; Bart Devreese; Karine H Hellemans; Zhidong Ling; Christiaan Van Schravendijk; Daniel G Pipeleers; Johannes P C Vissers; Frans K Gorus Journal: PLoS One Date: 2010-12-06 Impact factor: 3.240